ReShape Lifesciences Inc
NASDAQ:RSLS
ReShape Lifesciences Inc
NASDAQ:RSLS
Price:
0.1698 USD
-4.61%
Market Closed
Updated:
Apr 27, 2024
ReShape Lifesciences Inc
Cash from Investing Activities
|
ReShape Lifesciences Inc
Cash from Investing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ReShape Lifesciences Inc
NASDAQ:RSLS
|
Cash from Investing Activities
-$10k
|
CAGR 3-Years
61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.6B
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-18%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$962m
|
CAGR 3-Years
41%
|
CAGR 5-Years
20%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is ReShape Lifesciences Inc's Cash from Investing Activities?
Cash from Investing Activities
-10k
USD
-10k
USD
Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Cash from Investing Activities amounts to -10k USD.
What is ReShape Lifesciences Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
61%
61%
Over the last year, the Cash from Investing Activities growth was 89%. The average annual Cash from Investing Activities growth rates for ReShape Lifesciences Inc have been 61% over the past three years .
You don't have any saved screeners yet
